Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0NZU stock hub

LON/0NZU has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0NZUis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.8B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0NZU

In the news

Latest news · LON/0NZU

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23.7

P25 n/aP50 n/aP75 n/a

Trailing P/E3.7

P25 n/aP50 n/aP75 n/a

ROE56.2

P25 n/aP50 n/aP75 n/a

ROIC2,303.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0NZU market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

192

Groups with data

Currency

DKK

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Denmark
Country code	UK
Employees	491
Employees Change	146%
Employees Change Percent	41.13
Enterprise value	DKK 1.2B
Exchange	London Stock Exchange
Financial currency	DKK
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Isin	DK0060257814
Last refreshed	2026-05-10
Market cap	DKK 2.8B
Price	DKK 333
Price currency	DKK
Rev Per Employee	2,198,777.61x
Sic	2836
Symbol	lon/0NZU
Website	https://www.zealandpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	26.81%
EV Earnings	1.56x
EV/EBIT	1.48x
EV/EBITDA	1.48x
EV/FCF	1.57x
EV/Sales	1.09x
FCF yield	26.51%
Forward P/E	23.7x
P/B ratio	1.65x
P/E ratio	3.73x
P/S ratio	2.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	73.41%
EBITDA Margin	73.58%
FCF margin	68.43%
Gross margin	99.99%
Gross Profit	DKK 1.1B
Gross Profit Growth	17,558.95%
Gross Profit Growth Q	325%
Gross Profit Growth3 Y	342.48%
Gross Profit Growth5 Y	104.87%
Net Income	DKK 747.2M
Pretax Margin	75.13%
Profit Margin	69.21%
Profit Per Employee	DKK 1.5M
ROA	34.72
Roa5y	-10.72
ROCE	45.54
ROE	56.16
Roe5y	-41.05
ROIC	2,303.7
Roic5y	-24.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.69%
Cagr15y	11.76%
Cagr1y	-22.19%
Cagr3y	17.16%
Cagr5y	13.14%
Revenue Growth	16,519.65x
Revenue Growth Q	325x
Revenue Growth3 Y	342.49x
Revenue Growth5 Y	92.83x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	DKK 0.76
Assets	DKK 1.8B
Cash	DKK 1.7B
Current Assets	DKK 1.7B
Current Liabilities	DKK 46.7M
Debt	DKK 48.4M
Debt EBITDA	DKK 0.06
Debt Equity	DKK 0.03
Debt FCF	DKK 0.07
Equity	DKK 1.7B
Interest Coverage	260.3
Liabilities	DKK 97.2M
Long Term Assets	DKK 50.2M
Long Term Liabilities	DKK 50.5M
Net Cash	DKK 1.6B
Net Cash By Market Cap	DKK 58.92
Net Cash Growth	72.45%
Net Debt EBITDA	DKK -2.07
Net Debt Equity	DKK -0.97
Net Debt FCF	DKK -2.22
Tangible Book Value	DKK 1.7B
Tangible Book Value Per Share	DKK 23.85
WACC	7.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	37.17
Net Working Capital	DKK 20.4M
Quick ratio	36.4
Working Capital	DKK 1.7B
Working Capital Turnover	DKK 0.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.13%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	175.97%
1Y total return	-22.18%
200-day SMA	407.5
3Y total return	60.83%
50-day SMA	303.9
50-day SMA vs 200-day SMA	50under200
5Y total return	85.35%
All Time High	969
All Time High Change	-63.37%
All Time High Date	2024-07-05
All Time Low	47
All Time Low Change	655.19%
All Time Low Date	2011-11-02
ATR	17.76
Beta	0.57
Ch YTD	-24.45
High	345.9
High52	555.3
High52 Date	2025-11-20
High52ch	-39.97%
Low	325.7
Low52	233.2
Low52 Date	2026-03-09
Low52ch	42.95%
Ma50ch	16.8%
Price vs 200-day SMA	-12.89%
RSI	58.48
RSI Monthly	40.16
RSI Weekly	43.56
Sharpe ratio	-0.32x
Sortino ratio	-0.33
Total Return	-4.13%
Tr YTD	-24.45
Tr15y	429.76%
Tr1m	24.31%
Tr1w	15.3%
Tr3m	-12.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	DKK 792.6M
Operating margin	73.41

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	56,711,683%
Net Borrowing	-2,910,964.5
Shares Insiders	0.42%
Shares Institutions	33.42%
Shares Qo Q	0.36%
Shares Yo Y	4.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	DKK 724.2M
Average Volume	23,713.15x
Bv Per Share	23.93
CAPEX	DKK -4.4M
Ch10y	176
Ch15y	429.8
Ch1m	24.31
Ch1w	15.3
Ch1y	-22.18
Ch3m	-12.23
Ch3y	60.83
Ch5y	85.35
Ch6m	-17.78
Change	-6.08%
Change From Open	-3.37
Close	354.9
Days Gap	-2.8
Depreciation Amortization	1,729,202.2
Dollar Volume	4,524,089.9
Earnings Date	2026-05-07
EBIT	DKK 792.6M
EBITDA	DKK 794.3M
EPS	DKK 10.45
F Score	6
FCF	DKK 738.8M
FCF EV Yield	63.57x
Financing CF	-45,000,402
Fiscal Year End	December
Founded	1,997
Graham Number	637.69216
Graham Upside	91.29
Income Tax	DKK 63.9M
Investing CF	-341,082,768
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Ma150	408.6
Ma150ch	-13.13%
Ma20	310.2
Ma20ch	14.44%
Net CF	358,957,828
Next Earnings Date	2026-08-13
Open	345
P FCF Ratio	3.77
P OCF Ratio	3.75
Position In Range	37.94
Ppne	18,972,982.1
Price Date	2026-05-08
Price EBITDA	DKK 3.51
Ptbv Ratio	1.65
Relative Volume	0.57x
Revenue	1,079,599,805x
SBC By Revenue	1.35x
Share Based Comp	14,590,765
Tax By Revenue	5.92x
Tax Rate	7.88%
Tr6m	-17.78%
Volume	13,571
Z Score	24.53

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0NZU pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0NZU stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0NZU?

Insider, institutional, and short-interest positioning.

Institutional ownership

+33.4%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.1%

Negative means the company is buying back shares.

Technical

LON/0NZU momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.5

Neutral momentum band

Price vs 200-day MA

-12.9%

50/200-day relationship not available

Beta (5Y)

0.57

Less volatile than the market

Sharpe ratio

-0.32

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0NZU

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0NZU stock rating?

lon/0NZU is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0NZU analysis?

The full report lives at /stocks/lon/0NZU/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0NZU?

The latest report frames lon/0NZU around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0NZU page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.